Bring us a protein target.
Discuss recombinant protein development around a defined use case and material requirements.
Discuss your project ↗Evaluate a full-length stable isotope-labeled recombinant IGF-1 internal standard in your quantitative LC-MS/MS workflow.
For clinical mass spectrometry, reference laboratories, and assay development teams.
A protein-level standard introduced before relevant processing and digestion can accompany more of the analytical workflow.
Explore the analytical rationale ↗A standard cannot account for changes before its addition. Method fit depends on the matrix, analyte behavior, and assay design.
Both support downstream LC-MS/MS measurement; they enter the workflow at different stages.
Can accompany more of the analytical processing when added before those steps.
Helps normalize downstream measurement; the peptide itself does not undergo protein processing or digestion.
Earlier introduction allows a full-length SIL protein to share more analytical steps with the endogenous analyte. The extent of process control depends on the addition point and method.
The current flagship material for quantitative IGF-1 LC-MS/MS method development. Review its fit in your intended matrix and preparation route.
Discuss recombinant protein development around a defined use case and material requirements.
Discuss your project ↗Explore use in quantitative protein LC-MS/MS development and related analytical programs.
Explore applications ↗Tell us about your assay, matrix, and evaluation requirements. We can align the next technical discussion to your method.